PMC:7696151 / 4268-4576 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"117","span":{"begin":234,"end":241},"obj":"Chemical"},{"id":"119","span":{"begin":159,"end":167},"obj":"Disease"},{"id":"139","span":{"begin":259,"end":261},"obj":"Chemical"},{"id":"140","span":{"begin":266,"end":269},"obj":"Chemical"},{"id":"141","span":{"begin":290,"end":299},"obj":"Chemical"}],"attributes":[{"id":"A117","pred":"tao:has_database_id","subj":"117","obj":"MESH:D002244"},{"id":"A119","pred":"tao:has_database_id","subj":"119","obj":"MESH:D064420"},{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"MESH:D002738"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"MESH:D006886"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"MESH:D010710"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ity. Instead, the therapeutic ratio is decreased by substitution of the alkyl side chain with an aryl chain. Nevertheless, the therapeutic ratio decreases and toxicity increases with an increase of the alkyl side-chain length above 5 carbons [7,10].\nUsually, CQ and HCQ are administered as phosphate and sulp"}

{"project":"LitCovid-sentences","denotations":[{"id":"T34","span":{"begin":5,"end":108},"obj":"Sentence"},{"id":"T35","span":{"begin":109,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ity. Instead, the therapeutic ratio is decreased by substitution of the alkyl side chain with an aryl chain. Nevertheless, the therapeutic ratio decreases and toxicity increases with an increase of the alkyl side-chain length above 5 carbons [7,10].\nUsually, CQ and HCQ are administered as phosphate and sulp"}